Analytical Data
-
基因名
GPR162
- Application
-
别名
GPR162; GRCA; Probable G-protein coupled receptor 162; Gene-rich cluster gene A protein
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q16538
-
表达区间
1-304aa
-
氨基酸序列
MLSTGVVSFFSLKSDSAPPWMVLAVLWCSMAQTLLLPSFIWSCERYRADVRTVWEQCVAIMSEEDGDDDGGCDDYAEGRVCKVRFDANGATGPGSRDPAQVKLLPGRHMLFPPLERVHYLQVPLSRRLSHDETNIFSTPREPGSFLHKWSSSDDIRVLPAQSRALGGPPEYLGQRHRLEDEEDEEEAEGGGLASLRQFLESGVLGSGGGPPRGPGFFREEITTFIDETPLPSPTASPGHSPRRPRPLGLSPRRLSLGSPESRAVGLPLGLSAGRRCSLTGGEESARAWGGSWGPGNPIFPQLTL
-
分子量
59.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GPR162 is a member of the G protein-coupled receptor (GPCR) family, which plays a crucial role in various physiological processes and signaling pathways. Initial investigations have indicated that GPR162 is predominantly expressed in the brain and may be involved in the regulation of neurophysiological functions. Given the significant role of GPCRs in drug discovery and their implications in numerous diseases, including neurological disorders, the need for a deeper understanding of GPR162's structure and function has emerged. Recent studies have focused on the recombinant expression of GPR162 protein to facilitate the analysis of its functional properties, ligand interactions, and downstream signaling mechanisms. By producing a stable recombinant form of GPR162, researchers aim to elucidate its role in cellular signaling and its potential as a therapeutic target. This research not only contributes valuable data to the GPCR field but also enhances the understanding of the molecular basis of GPR162's functions, paving the way for future drug development efforts aimed at modulating its activity in various pathophysiological contexts. The recombinant protein provides a foundational tool for functional assays, structure-based drug design, and the exploration of GPR162's involvement in neuropsychological conditions, potentially leading to novel therapeutic approaches.
